Phase 1 Study of ONO-7475 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Clinical trial NCT03730337 · COMPLETED

Trial details

NCT number: NCT03730337
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Solid Tumors

Start date: 2018-10-17
Primary completion: 2021-06-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.